» Articles » PMID: 36167810

Generation of a Recombinant Version of a Biologically Active Cell-permeant Human HAND2 Transcription Factor from E. Coli

Overview
Journal Sci Rep
Specialty Science
Date 2022 Sep 27
PMID 36167810
Authors
Affiliations
Soon will be listed here.
Abstract

Transcription factor HAND2 has a significant role in vascularization, angiogenesis, and cardiac neural crest development. It is one of the key cardiac factors crucial for the enhanced derivation of functional and mature myocytes from non-myocyte cells. Here, we report the generation of the recombinant human HAND2 fusion protein from the heterologous system. First, we cloned the full-length human HAND2 gene (only protein-coding sequence) after codon optimization along with the fusion tags (for cell penetration, nuclear translocation, and affinity purification) into the expression vector. We then transformed and expressed it in Escherichia coli strain, BL21(DE3). Next, the effect (in terms of expression) of tagging fusion tags with this recombinant protein at two different terminals was also investigated. Using affinity chromatography, we established the one-step homogeneous purification of recombinant human HAND2 fusion protein; and through circular dichroism spectroscopy, we established that this purified protein had retained its secondary structure. We then showed that this purified human protein could transduce the human cells and translocate to its nucleus. The generated recombinant HAND2 fusion protein showed angiogenic potential in the ex vivo chicken embryo model. Following transduction in MEF2C overexpressing cardiomyoblast cells, this purified recombinant protein synergistically activated the α-MHC promoter and induced GFP expression in the α-MHC-eGFP reporter assay. Prospectively, the purified bioactive recombinant HAND2 protein can potentially be a safe and effective molecular tool in the direct cardiac reprogramming process and other biological applications.

Citing Articles

Can we stop one heart from breaking: triumphs and challenges in cardiac reprogramming.

Spurlock B, Liu J, Qian L Curr Opin Genet Dev. 2023; 83:102116.

PMID: 37797568 PMC: 10872832. DOI: 10.1016/j.gde.2023.102116.

References
1.
Haridhasapavalan K, Kumar Sundaravadivelu P, Thummer R . Codon Optimization, Cloning, Expression, Purification, and Secondary Structure Determination of Human ETS2 Transcription Factor. Mol Biotechnol. 2020; 62(10):485-494. DOI: 10.1007/s12033-020-00266-8. View

2.
Zang M, Li Y, Wang H, Wang J, Jia H . Cooperative interaction between the basic helix-loop-helix transcription factor dHAND and myocyte enhancer factor 2C regulates myocardial gene expression. J Biol Chem. 2004; 279(52):54258-63. DOI: 10.1074/jbc.M408502200. View

3.
Braun P, Hu Y, Shen B, Halleck A, Koundinya M, Harlow E . Proteome-scale purification of human proteins from bacteria. Proc Natl Acad Sci U S A. 2002; 99(5):2654-9. PMC: 122403. DOI: 10.1073/pnas.042684199. View

4.
Baeshen M, Al-Hejin A, Bora R, Ahmed M, Ramadan H, Saini K . Production of Biopharmaceuticals in E. coli: Current Scenario and Future Perspectives. J Microbiol Biotechnol. 2015; 25(7):953-62. DOI: 10.4014/jmb.1412.12079. View

5.
Zang M, Li Y, Xue L, Jia H, Jing H . Cooperative activation of atrial naturetic peptide promoter by dHAND and MEF2C. J Cell Biochem. 2004; 93(6):1255-66. DOI: 10.1002/jcb.20225. View